NOT KNOWN FACTS ABOUT AZELAPRAG AMGEN

Azelaprag was properly tolerated During this review and in the least doses tested to this point in 227 subjects, with a safety profile per the conclusions of prior stage one trials done by Amgen.Strong cytochrome P450 3A4 and/or P-glycoprotein inhibitors may warrant AMG 986 dose reduction and should be coadministered with warning in people with cor